BPC-157 is not FDA approved as a standard medication, and the FDA has identified concerns around compounded BPC-157, including possible immunogenicity risk, peptide-related impurities, and limited safety information for certain routes of administration
William Seeds protocol From the peptide reference text "Peptide Protocols, Volume 1": Dose: 100mcg subcutaneously Timing: Approximately 3 hours before bedtime Frequency: Can be done daily, every 3 days, or weekly depending on response This flexible approach allows individualization based on how you respond
Last updated: March 9, 2026 If you are considering B12 injections this spring whether as part of a pre-summer wellness refresh or to address persistent fatigue understanding the risks is just as important as knowing the benefits
BPC-157 shows similarly favorable safety profiles in available research
Su etiopatogenia es desconocida, aunque podra deberse a la inhibicin del receptor del RFEC a nivel de la epidermis y del folculo piloso